Single-Agent GvHD prophylaxis with tacrolimus after post-Transplant high-dose cyclophosphamide is a valid option for haploidentical transplantation in adults with hematological malignancies
A. Esquirol, M. J. Pascual, M. Ortiz, J. L. Piñana, C. Ferra, I. Garcia Cadenas, I. Vilades, S. Brunet, R. Martino, J. Sierra
Fingerprint
Dive into the research topics of 'Single-Agent GvHD prophylaxis with tacrolimus after post-Transplant high-dose cyclophosphamide is a valid option for haploidentical transplantation in adults with hematological malignancies'. Together they form a unique fingerprint.